AstraZeneca (AZN) News Today $66.60 -0.31 (-0.46%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period AstraZeneca (AZN) Reels from China Investigation and Investor Suit – Hagens BermanJanuary 20 at 3:16 PM | globenewswire.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZNJanuary 20 at 2:33 PM | investing.comThe Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming ...January 20 at 6:08 AM | gurufocus.comThe Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline - AZNJanuary 20 at 5:45 AM | prnewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZNJanuary 19 at 12:32 PM | investing.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Oak Ridge Investments LLCOak Ridge Investments LLC raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 5.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,973 shares of the company's stock afJanuary 19 at 7:33 AM | marketbeat.comROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZNJanuary 18 at 9:21 AM | globenewswire.comProfessional Advisory Services Inc. Raises Stake in AstraZeneca PLC (NASDAQ:AZN)Professional Advisory Services Inc. raised its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 20.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 332,945 shares of the company's stock aftJanuary 18 at 6:30 AM | marketbeat.comAstraZeneca: Diverse Clinical Pipeline Meeting Future Demand, In Undervalued SectorJanuary 18 at 6:13 AM | seekingalpha.comAstraZeneca PLC (NASDAQ:AZN) Position Cut by Boston Common Asset Management LLCBoston Common Asset Management LLC reduced its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 12.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 55,110 shares of the company's stock after selling 7January 18 at 5:51 AM | marketbeat.comProcyon Advisors LLC Has $2.21 Million Stake in AstraZeneca PLC (NASDAQ:AZN)Procyon Advisors LLC grew its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 12.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 33,695 shares of the company's stock after purchasing an additional 3,January 18 at 5:26 AM | marketbeat.com23,847 Shares in AstraZeneca PLC (NASDAQ:AZN) Purchased by Empirical Asset Management LLCEmpirical Asset Management LLC acquired a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 23,847 shares of the company's stock, valued at approximately $January 18 at 4:59 AM | marketbeat.comDATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast CancerJanuary 17 at 5:35 PM | businesswire.comAZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJanuary 17 at 4:00 PM | globenewswire.comAstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption – Hagens BermanJanuary 17 at 1:56 PM | globenewswire.comUS FDA approves AstraZeneca's drug for breast cancerJanuary 17 at 1:30 PM | reuters.comAstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJanuary 17 at 12:00 PM | prnewswire.comLowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the FirmJanuary 17 at 11:39 AM | globenewswire.comFaruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 – AZNJanuary 17 at 9:47 AM | globenewswire.comChannel Wealth LLC Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)Channel Wealth LLC grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 144.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 40,175 shares of the company's stock after purchasing an additional 23,7January 17 at 8:17 AM | marketbeat.comRitholtz Wealth Management Sells 14,968 Shares of AstraZeneca PLC (NASDAQ:AZN)Ritholtz Wealth Management cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 18.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 68,370 shares of the company's stock after selliJanuary 17 at 6:08 AM | marketbeat.comAstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AZNJanuary 17 at 5:45 AM | prnewswire.comAstraZeneca PLC (NASDAQ:AZN) Short Interest UpdateAstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 12,690,000 shares, a growth of 26.1% from the December 15th total of 10,060,000 shares. Based on an average trading volume of 5,590,000 shares, the short-interest ratio is presently 2.3 days.January 16, 2025 | marketbeat.comAZN Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the AstraZeneca PLC Class ActionJanuary 16, 2025 | prnewswire.comAZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit Filed by The Rosen Law FirmJanuary 16, 2025 | prnewswire.comContact Levi & Korsinsky by February 21, 2025 Deadline to Join Class Action Against AstraZeneca PLC (AZN)January 16, 2025 | globenewswire.comShareholders that lost money on AstraZeneca PLC(AZN) should contact The Gross Law Firm about pending Class Action - AZNJanuary 16, 2025 | prnewswire.comPark Avenue Securities LLC Acquires 14,711 Shares of AstraZeneca PLC (NASDAQ:AZN)Park Avenue Securities LLC raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 23.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,312 shares of the company's stock after acquiring an adJanuary 16, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Stock Position Reduced by Assenagon Asset Management S.A.Assenagon Asset Management S.A. decreased its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 2.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 849,388 shares of the company's stockJanuary 16, 2025 | marketbeat.comPines Wealth Management LLC Invests $378,000 in AstraZeneca PLC (NASDAQ:AZN)Pines Wealth Management LLC bought a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,646 shares of the company's stoJanuary 16, 2025 | marketbeat.comAZN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitJanuary 15, 2025 | globenewswire.comAstraZeneca (AZN) Reels from China Investigation and Investor Suit–Hagens BermanJanuary 15, 2025 | globenewswire.comAstraZeneca PLC Sued for Securities Law Violations - Contact The Gross Law Firm Before February 21, 2025 to Discuss Your Rights – AZNJanuary 15, 2025 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZenecaJanuary 15, 2025 | prnewswire.comROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZNJanuary 15, 2025 | globenewswire.comCox Capital Mgt LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)Cox Capital Mgt LLC raised its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 61.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 60,606 shares of the company's stock after purchasing an aJanuary 15, 2025 | marketbeat.comCommunity Trust & Investment Co. Acquires 8,903 Shares of AstraZeneca PLC (NASDAQ:AZN)Community Trust & Investment Co. lifted its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 183,523 shares of the company's stock after acquiringJanuary 15, 2025 | marketbeat.com3 High-Yielding Dividend Stocks That Are Trading at Dirt Cheap PricesJanuary 15, 2025 | fool.comIs AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros’ Portfolio?January 14, 2025 | msn.comAstraZeneca PLC Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZNJanuary 14, 2025 | prnewswire.comMiracle Mile Advisors LLC Boosts Position in AstraZeneca PLC (NASDAQ:AZN)Miracle Mile Advisors LLC grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 445.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,986 shares of the company's stock after buying anJanuary 14, 2025 | marketbeat.comAZN Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the AstraZeneca PLC Class ActionJanuary 13, 2025 | globenewswire.comAstraZeneca PLC Investors: Please contact the Portnoy Law Firm to recover your losses. February 21, 2025 Deadline to file Lead Plaintiff MotionJanuary 13, 2025 | globenewswire.comROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZNJanuary 13, 2025 | investing.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca Lawsuit – AZNJanuary 13, 2025 | globenewswire.comAstraZeneca (AZN) Reels from China Investigation and Investor Suit – Hagens BermanJanuary 13, 2025 | globenewswire.comAZN INVESTOR DEADLINE: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJanuary 13, 2025 | prnewswire.comShareholders that lost money on AstraZeneca PLC(AZN) should contact The Gross Law Firm about pending Class Action - AZNJanuary 13, 2025 | prnewswire.comNordea Investment Management AB Acquires New Holdings in AstraZeneca PLC (NASDAQ:AZN)Nordea Investment Management AB acquired a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 11,478 shares of the company's stock, valued at approximately $754,000. Several other institutional investors anJanuary 13, 2025 | marketbeat.comROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZNJanuary 12, 2025 | globenewswire.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.350.44▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼4221▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenx News BioNTech News Teva Pharmaceutical Industries News BeiGene News Summit Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
